<DOC>
	<DOCNO>NCT01275365</DOCNO>
	<brief_summary>This randomize , placebo-controlled , parallel group , double blind , clinical trial community dwelling , old men , 65 year age old , mobility limitation low protein intake . The study 2 X 2 factorial design , allow u investigate effect dietary protein intake testosterone separately together .</brief_summary>
	<brief_title>Optimizing Protein Intake Older Americans With Mobility Limitations</brief_title>
	<detailed_description>The recommended dietary allowance ( RDA ) protein , set 0.8 grams/kg/day adult men woman , engendered debate many expert advocate protein intake substantially RDA help maintain muscle anabolism old individual . It know whether increase protein intake old Americans , whose current intake RDA , increase skeletal muscle mass , muscle performance physical function . Our first aim determine whether administration 1.3 g/kg/day protein , compare RDA ( 0.8 g/kg/day ) , result great improvement lean body mass , maximal voluntary muscle strength power , self-reported performance-based measure physical function old men . Our second aim determine whether gain lean body mass , maximal voluntary strength self-reported performance-based measure physical function testosterone administration great 1.3 g protein RDA old men eucaloric diet . We conduct randomize , placebo-controlled , double-blind trial use 2 X 2 factorial design . Community dwell men , 65 year old , self-reported mobility limitation , daily protein intake &lt; 0.8 g/kg/day contraindication testosterone therapy , randomly assign one four group : placebo injection plus protein 0.8 g/kg/day ; placebo injection plus protein 1.3 g/kg/day ; testosterone enanthate 100 mg weekly plus protein 0.8 g/kg/day ; testosterone enanthate 100 mg weekly plus protein 1.3 g/kg/day . Treatment duration 6 month . The primary outcome change lean body mass baseline 6 month , measure dual energy X-ray absorptiometry . Secondary outcome include change maximal voluntary strength leg chest press exercise , leg power , self-reported ( physical function domain SF-36 ) performance-based measure physical function ( 6-min walking distance speed , stair climb power , load carrying ) , fatigue , well-being affectivity balance . Safety measure include urinary calcium excretion , hematocrit , prostate specific antigen ( PSA ) prostate examination .</detailed_description>
	<mesh_term>Mobility Limitation</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>1 . Communitydwelling men 65 year age old 2 . A score 310 short physical performance battery ( SPPB ) 3 . Daily protein intake less recommended daily allowance 0.83 g/kg/day ( 3 24hour food recall ) 4 . Able give inform consent 1 . History prostate breast cancer 2 . American Urological Association [ AUA ] symptom index score &gt; 19 3 . Prostate specific antigen ( PSA ) &gt; 4 ng/ml White men &gt; 3 ng/ml Black men 4 . Prostate specific antigen ( PSA ) &gt; 4 ng/ml nonBlack men &gt; 3 ng/ml Black men . These subject may enrol negative transrectal biopsy within past year . 5 . Myocardial infarction stroke within last 6 month 6 . Uncontrolled congestive heart failure , base study physician 's evaluation 7 . Serum creatinine &gt; 2.0 mg/dL ; men kind dialysis exclude . 8 . History celiac disease , Crohn 's disease , ulcerative colitis 9 . History malignancy require treatment within previous 2 year , except nonmelanic skin cancer . Men cancer require active treatment within past two year disease recurrence within past two year may enrol discretion study physician . 10 . Neuromuscular disease : motor neuron disease , multiple sclerosis , adult muscular dystrophy , myasthenia gravis 11 . History stroke residual limb weakness affect individual 's ability walk ; subject history stroke residual limb weakness may enrol . 12 . Schizophrenia , bipolar disorder , untreated diagnosed depression . Subjects unipolar depression antidepressant medication eligible . 13 . TSH level &lt; 0.4 &gt; 5 mlU/L 14 . Systolic blood pressure ( BP ) &gt; 160 diastolic BP &gt; 100 mm Hg ( average 2 measurement take Visit 1 ) 15 . Hemoglobin A1c &gt; 8.0 % take insulin . Men diabetes mellitus whose A1C le 8.0 % take insulin eligible . 16 . MiniMental Status Exam [ MMSE ] &lt; 24 17 . Body mass index ( BMI ) less 20 great 40 kg/m2 18 . Not willing eat following : red meat , egg , poultry , fish shellfish 19 . Allergy sesame , peanut , soy , gluten shellfish 20 . Current alcohol use &gt; 21 drinks/week base selfreport 21 . Confinement wheelchair 22 . Use anabolic therapy ( Testosterone , DHEA , androstenedione , rhGH ) within past year 23 . Current use levodopa anticoagulant 24 . Current enrollment structure weight management program participation weight intervention study last 90 day 25 . Serum ALT AST great 3 x upper limit normal 26 . Hematocrit &lt; 30 % &gt; 48 % 27 . Subject able eat 3 frozen study meal per day 6 month 28 . Subject unwilling stop current nutritional supplement 29 . Progressive intensive resistance training within 12 week screen 30 . Noncompliant runin diet and/or supplement</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Mobility Limitation</keyword>
	<keyword>Low Protein Intake</keyword>
	<keyword>Older Men</keyword>
	<keyword>Testosterone</keyword>
</DOC>